DiscoverStartupsAria PharmaceuticalsAria Pharmaceuticals Funding Rounds, Valuation & Investors
Aria Pharmaceuticals company logo
Aria Pharmaceuticals
Aria Pharmaceuticals is a pre-clinical stage pharmaceutical company11-50 Employees
  • B2B
  • Growth Stage
    Expanding market presence
  • Top Investors
    This company has received a significant amount of investment from top investors
View 0 jobs

Aria Pharmaceuticals Funding

$10M
11 round
Aria Pharmaceuticals is active in the following markets / industries: biotechnology, pharmaceuticals, artificial intelligence and big data analytics. The company has secured funding across 1 rounds, totaling in an amount of $10M. Their most recent funding was raised on March 19, 2018.

Funding Rounds

A
$10000000
Series AMar 2018$0 valuation
Avatar for SoftBank Ventures Korea
Avatar for Andreessen Horowitz
Avatar for OS Fund
Press
Soft Bank Ventures Leads $10 M Investment Ai Driven Drug

Investors of Aria Pharmaceuticals

SoftBank Ventures Korea
VC Firm • Seoul
Avatar for SoftBank Ventures Korea
Rounds
A
Andreessen Horowitz
VC Firm • Menlo Park
Avatar for Andreessen Horowitz
Helping the greatest tech entrepreneurs build the best tech companies
Rounds
A
OS Fund
VC Firm
Avatar for OS Fund
Rounds
A
Haya Al Ghanim
Angel Investor
Avatar for Haya Al Ghanim
Founded several non-profit development programs, then founded Oola Sportswear. BA in Molecular & Cellular Bio from CU, Boulder 2007 and MBA from MIT Sloan 2014
CLI Ventures
VC Firm • Palo Alto
Avatar for CLI Ventures
VC
StartX
VC Firm • Palo Alto
Avatar for StartX
The @Stanford Startup Accelerator
Back to People
Onwards to Jobs